Viewing Study NCT03637803


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-30 @ 4:25 AM
Study NCT ID: NCT03637803
Status: TERMINATED
Last Update Posted: 2023-06-01
First Post: 2018-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
Sponsor: 4D pharma plc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module